BridgeMD
New treatment option for Anxiety
Official title Aromatherapy for Mental Health Promotion in IVF Patients
ClinicalTrials.gov ID: NCT07480668
What this study is testing
- What it's testing
- The experience of infertility can cause significant emotional instability, especially for patients awaiting In Vitro Fertilization (IVF) treatment, generating anxiety, stress, and depressive symptoms. This study is a randomized clinical trial assessing the effectiveness of aromatherapy in improving mental health and quality of life in women undergoing infertility treatment.
- Time commitment: about 4 weeks
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Female gender, age over 18 years.
- Diagnosis of infertility with indication for In Vitro Fertilization (IVF).
- Patients on the waiting list at HC-UFMG.
- Agreement not to practice other mind-body or herbal complementary therapies during the study.
- DASS-21 screening score compatible with at least mild anxiety, stress, and/or depression.
You likely can't join if
- Severe neurological, psychiatric, or clinical disorders (e.g., schizophrenia, severe depression) that prevent participation.
- Use of medications that could confound the primary outcome (e.g., sleep medications, anxiolytics, antidepressants, neuroleptics) in the 30 days prior...
- Known allergy to lavender products.
- Pregnancy during the study period.
- Use of essential oils in the last 90 days.
See the full eligibility criteria
- Female gender, age over 18 years.
- Diagnosis of infertility with indication for In Vitro Fertilization (IVF).
- Patients on the waiting list at HC-UFMG.
- Agreement not to practice other mind-body or herbal complementary therapies during the study.
- DASS-21 screening score compatible with at least mild anxiety, stress, and/or depression.
- No aversion to inhaling essential oil or synthetic lavender essence.
- Severe neurological, psychiatric, or clinical disorders (e.g., schizophrenia, severe depression) that prevent participation.
- Use of medications that could confound the primary outcome (e.g., sleep medications, anxiolytics, antidepressants, neuroleptics) in the 30 days prior to or during the study.
- Known allergy to lavender products.
- Pregnancy during the study period.
- Use of essential oils in the last 90 days.
The study team makes the final eligibility decision.
Where it's taking place
- Belo Horizonte, Minas Gerais, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Belo Horizonte, Minas Gerais, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.